ArticleScientific reports2025
Baseline and longitudinal patterns of Non-HDL-C to HDL-C ratio (NHHR) and major adverse cardiovascular events in peripheral artery disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Non-HDL-to-HDL-cholesterol ratio and metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.BMC gastroenterology · 2026Pooled it
- Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and peripheral artery disease in vascular surgery inpatients aged 50 and above: a retrospective cross-sectional study.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is an innovative lipid parameter for atherosclerosis risk, yet its association with major adverse cardiovascular events (MACE) in peripheral artery disease (PAD) patients remains unclear. We retrospectively analyzed 13,224 PAD patients in Hong Kong, assessing baseline NHHR and longitudinal NHHR trajectories as predictors of MACE using spline models, latent class growth modeling, and Cox proportional hazards models. Over a median follow-up of 3.4 years, a U-shaped relationship emerged between baseline NHHR and MACE risk. Patients in the highest quintile of NHHR (Q5) had a significantly increased risk of MACE (HR = 1.16, 95% CI: 1.07-1.25, P < 0.001), as did those in the lowest quintile (Q1) (HR = 1.17, 95% CI: 1.08-1.27, P < 0.001), compared with the reference group. Among five NHHR trajectories, moderate-high-stable (HR = 1.17 [95% CI: 1.04-1.32], P < 0.001) and high-stable groups (HR = 1.35 [95% CI: 1.14-1.60], P < 0.001) showed higher risk, whereas the declining group had no increased risk (HR = 1.04 [95% CI: 0.88-1.23], P = 0.356). High and low baseline NHHR, as well as persistently elevated trajectories, were associated with higher MACE risk in PAD, whereas declining trajectories normalized this risk. NHHR may serve as a useful marker for cardiovascular risk stratification in PAD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.